Global Pharma Companies Begin Conducting Comparative Effectiveness Research During Phase 3 of Product Development RESEARCH TRIANGLE PARK, NC--(Marketwired - June 26, 2017) - Research from global market access teams found that pharmaceutical and medical device companies often wait until Phase 3 or later to...